GH1 and endometrial cancer: Conversely, the functional inhibition of GH signaling using a specific GH receptor antagonist in endometrial cancer cells sensitizes cells to ionizing radiation-induced cell death and enhances the induction of DNA damage (Bougen et al., 2012).